A Study of Brenipatide in Participants With Opioid Use Disorder

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Opioid Use Disorder

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • NoesisPharma - Phoenix - East Shea Boulevard, Phoenix, Arizona, United States

    Contact: Principal Investigator (John Prater)
  • Pillar Clinical Research- Little Rock, Little Rock, Arkansas, United States

    Contact: Principal Investigator (Leslie Smith)
  • Woodland International Research Group, Little Rock, Arkansas, United States

    Study coordinator · 501-221-8681
    Contact: Principal Investigator (George Konis)
  • Ark Clinical Research - Fountain Valley, Fountain Valley, California, United States

    Study coordinator · 714-988-2021
    Contact: Principal Investigator (Justin Yanuck)
  • Center on Substance Use and Health (CSUH), San Francisco, California, United States

    Contact: Principal Investigator (Phillip Coffin)
  • UCSF Weill Institute for Neurosciences - Substance Use Disorders Clinic - Mission Bay, San Francisco, California, United States

    Contact: Principal Investigator (Khaled Moussawi)
  • Bradenton Research Center, Inc., Bradenton, Florida, United States

    Study coordinator · 941-708-0005
    Contact: Principal Investigator (Eric Folkens)
  • K2 Medical Research - Daytona Beach, Daytona Beach, Florida, United States

    Contact: Principal Investigator (Esteban Olivera)
  • NextPhase Research Florida - Hollywood, Hollywood, Florida, United States

    Contact: Principal Investigator (Peter Ventre)
  • Accel Research Sites - Lakeland Clinical Research Unit, Lakeland, Florida, United States

    Study coordinator · 863-940-2087
    Contact: Principal Investigator (James Andersen)
  • Life Arc Research Centers - Miami, Miami, Florida, United States

    Study coordinator · 305-874-7401
    Contact: Principal Investigator (Janny Rivera)
  • Advanced Research for Health Improvement, LLC, Naples, Florida, United States

    Study coordinator · 239-230-2021
    Contact: Principal Investigator (Leonard Lado)
  • Innovative Research Institute - Port Charlotte, Port Charlotte, Florida, United States

    Study coordinator · 941-505-2100
    Contact: Principal Investigator (Joseph Ravid)
  • Better Years Ahead Medical Center, Tampa, Florida, United States

    Study coordinator · 813-709-8299
    Contact: Principal Investigator (Ana Suarez)
  • Neuroscience Research Institute - West Palm Beach, West Palm Beach, Florida, United States

    Contact: Principal Investigator (Danesh Alam)
  • Re:Cognition Health - Chicago, Chicago, Illinois, United States

    Contact: Principal Investigator (Abid Nazeer)
  • Indiana University Health Neuroscience Center, Indianapolis, Indiana, United States

    Contact: Principal Investigator (Michael Bushey)
  • University of Kentucky Chandler Medical Center, Lexington, Kentucky, United States

    Contact: Principal Investigator (Shanna Babalonis)
  • Maryland Treatment Centers - Mountain Manor Treatment Center, Baltimore, Maryland, United States

    Contact: Principal Investigator (Marc Fishman)
  • Maryland Treatment Centers - Avery Road Treatment Center, Rockville, Maryland, United States

    Contact: Principal Investigator (Marc Fishman)
  • Brigham and Women's Hospital, Boston, Massachusetts, United States

    Contact: Principal Investigator (Joji Suzuki)
  • Adams Clinical Boston, Boston, Massachusetts, United States

    Contact: Principal Investigator (Darin Dougherty)
  • Boston Medical Center, Boston, Massachusetts, United States

    Contact: Principal Investigator (Alyssa Peterkin)
  • Adams Clinical Watertown, Watertown, Massachusetts, United States

    Study coordinator · 617-744-8542
    Contact: Principal Investigator (Daniel Rutrick)
  • SKY Integrative Medical Center/SKYCRNG, Ridgeland, Mississippi, United States

    Study coordinator · 601-567-1321
    Contact: Principal Investigator (Bob Hutchins)
  • Adams Clinical Harlem, New York, New York, United States

    Study coordinator · 917-423-67697
    Contact: Principal Investigator (Rachel Noone)
  • Adams Clinical Bronx, The Bronx, New York, United States

    Contact: Principal Investigator (Shama Farooq)
  • Ohio Clinical Trials, Columbus, Ohio, United States

    Study coordinator · 380-210-2424
    Contact: Principal Investigator (Angela Eakin)
  • Rivus Wellness and Research Institute, Oklahoma City, Oklahoma, United States

    Study coordinator · 405-753-4994
    Contact: Principal Investigator (Marvin Peyton)
  • Adams Clinical Philadelphia, Philadelphia, Pennsylvania, United States

    Contact: Principal Investigator (Cassie Blanchard)
  • Penn Medicine: University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States

    Study coordinator · 610-639-3592
    Contact: Principal Investigator (Kyle Kampman)
  • Brown University School of Public Health, Providence, Rhode Island, United States

    Contact: Principal Investigator (Carolina Haass-Koffler)
  • Avera Research Institute - Sioux Falls, Sioux Falls, South Dakota, United States

    Study coordinator · 605-504-3154
    Contact: Principal Investigator (Vivek Anand)
  • Adams Clinical Dallas, DeSoto, Texas, United States

    Contact: Principal Investigator (Benji Kurian)
  • Biopharma Informatic, LLC, Houston, Texas, United States

    Study coordinator · 281-944-3610
    Contact: Principal Investigator (James Lai, MD)
  • University of Virginia Health System, Charlottesville, Virginia, United States

    Study coordinator · 434-243-0563
    Contact: Principal Investigator (Nassima Ait-Daoud Tiouririne)
  • Carilion Clinic, Roanoke, Virginia, United States

    Study coordinator · 540-981-8025
    Contact: Principal Investigator (Albert Arias)
  • University of Washington - Harborview Medical Center, Seattle, Washington, United States

    Contact: Principal Investigator (Elenore Bhatraju)
  • CaRe Clinic, Calgary, Canada

    Study coordinator · 587-955-3401
    Contact: Principal Investigator (Sumantra Ghosh)
  • Med Trust Research, Courtice, Canada

    Study coordinator · 905-728-7915
    Contact: Principal Investigator (Hamilton Jeyaraj)
  • The Medical Arts Health Research Group, Kamloops, Canada

    Contact: Principal Investigator (Dustin Janz)
  • Kelowna Health and Memory Centre, Kelowna, Canada

    Contact: Principal Investigator (Eugene Okorie)
  • Providence Care, Kingston, Canada

    Study coordinator · 6135444900
    Contact: Principal Investigator (Roumen Milev)
  • Malton Medical Group, Mississauga, Canada

    Study coordinator · 905-677-4200
    Contact: Principal Investigator (Brian Zidel)
  • Comprehensive Treatment Clinic, Toronto, Canada

    Contact: Principal Investigator (Leonard Bienenstock)
  • Centre for Addiction and Mental Health (CAMH), Toronto, Canada

    Contact: Principal Investigator (Bernard Le Foll)
  • Research Works San Juan, Guaynabo, Puerto Rico

    Study coordinator · 787-315-1669
    Contact: Principal Investigator (Jose Feliberti)
  • Surrey and Borders Partnership NHS Foundation Trust, Chertsey, United Kingdom

    Contact: Principal Investigator (CHRISTOS KOUIMTSIDIS)
  • St Pancras Clinical Research - Eastbourne, Eastbourne, United Kingdom

    Study coordinator · 020 3865 1142
    Contact: Principal Investigator (Graham Campbell)
  • Queen Elizabeth University Hospital, Glasgow, United Kingdom

    Study coordinator · (+44) 0141 232 7600
    Contact: Principal Investigator (Nagore Penades)
  • St Pancras Clinical Research, London, United Kingdom

    Study coordinator · 02038651142
    Contact: Principal Investigator (Ward Lawrence)
  • Bioluminux - London, London, United Kingdom

    Contact: Principal Investigator (Laxmi Patel)
  • Lambeth Drug and Alcohol Treatment Consortium, London, United Kingdom

    Contact: Principal Investigator (michael kelleher)
  • Greater Manchester Mental Health NHS Foundation Trust, Manchester, United Kingdom

    Contact: Principal Investigator (Stephen Kaar)
  • Bioluminux Clinical Research - Milton Keynes, Milton Keynes, United Kingdom

    Contact: Principal Investigator (Kayode Timothy)
  • Bioluminux - Southampton, Southampton, United Kingdom

    Contact: Principal Investigator (joshua asubiaro)
  • Old Bank House Hillingdon Drug & Alcohol, Uxbridge, United Kingdom

    Contact: Principal Investigator (Jeffrey Fehler)
  • Bioluminux - Wolverhampton, Wolverhampton, United Kingdom

    Contact: Principal Investigator (Joshua Olofinlade)
מובילי המחקר
  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Study Director

    Eli Lilly and Company